Home / Publications / 2010
"Significance of JAK2 and TET2 mutations in myelodysplastic syndromes". Hellstrom-Lindberg. Blood Reviews 24(2010);83-90
Hellström-Lindberg_Bloodreviews2010.pdf 442.52 kB
"Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy". Grovdal et al. British Journal of Haematology,150;293-302
Grovdal_BJH2010.pdf 498.41 kB
Last update: 2011-03-17 | 
Go Back | 
Print View
